Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 34346643!?!34346643 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34346643&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Ned+Tijdschr+Geneeskd 2021 ; 165 (?): ? Nephropedia Template TP {{tp|p=34346643|t=2021. 'Vaccine-induced immune thrombotic trombocytopenia' |pdf=|usr=}}{{34346643}} gab.com Text 'Vaccine-induced immune thrombotic trombocytopenia' JO: Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=34346643 #FOAvip Vaccine-induced immune thrombotic thrombocytopenia (VITT) is diagnosed if there is venous or arterial thrombosis with thrombocytopenia caused by antibodies against platelet factor 4 (PF4) that activate thrombocytes and is confirmed by a heparin-induced platelet activation (HIPA) test, occurring 4 to 28 days after vaccination against COVID19. This extremely rare syndrome has been recognized after Astra Zeneca (reporting incidence 0.91 per 100.000) and Janssen vaccins (0.22 per 100.000). Causality with the vaccine is difficult to ascertain if the HIPA test is negative, or if there is severe thrombosis (such as cerebral sinus or splanchnic thrombosis) without thrombocytopenia. Symptoms compatible with thrombosis or bleeding occurring in a specific time window after vaccination should prompt urgent assessment of the thrombocyte count and appropriate diagnostic tests. Heparin-like anticoagulants should be avoided and central laboratory assessment is essential. Early recognition likely improves prognosis of this extremely rare but severe complication of vaccination against COVID-19. Twit Text FOAVip 'Vaccine-induced immune thrombotic trombocytopenia' ????Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=34346643 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34346643 #FOAvip English Wikipedia <ref>{{Cite pmid|34346643}}</ref> 'Vaccine-induced immune thrombotic trombocytopenia' #MMPMID34346643 Middeldorp S Ned Tijdschr Geneeskd 2021[May]; 165 (?): ? PMID34346643show ga Vaccine-induced immune thrombotic thrombocytopenia (VITT) is diagnosed if there is venous or arterial thrombosis with thrombocytopenia caused by antibodies against platelet factor 4 (PF4) that activate thrombocytes and is confirmed by a heparin-induced platelet activation (HIPA) test, occurring 4 to 28 days after vaccination against COVID19. This extremely rare syndrome has been recognized after Astra Zeneca (reporting incidence 0.91 per 100.000) and Janssen vaccins (0.22 per 100.000). Causality with the vaccine is difficult to ascertain if the HIPA test is negative, or if there is severe thrombosis (such as cerebral sinus or splanchnic thrombosis) without thrombocytopenia. Symptoms compatible with thrombosis or bleeding occurring in a specific time window after vaccination should prompt urgent assessment of the thrombocyte count and appropriate diagnostic tests. Heparin-like anticoagulants should be avoided and central laboratory assessment is essential. Early recognition likely improves prognosis of this extremely rare but severe complication of vaccination against COVID-19. |*COVID-19[MESH] |*Thrombocytopenia/chemically induced[MESH] |*Thrombosis[MESH] |*Vaccines/adverse effects[MESH] |Anticoagulants[MESH] |Heparin[MESH] |Humans[MESH]'Vaccine-induced immune thrombotic trombocytopenia' (epmc).pdf DeepDyve Pubget Overpricing